Share Price and Basic Stock Data
Last Updated: December 27, 2025, 8:48 pm
| PEG Ratio | 47.26 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Expleo Solutions Ltd operates within the IT Consulting and Software sector, with a current market price of ₹992 and a market capitalization of ₹1,539 Cr. The company reported a significant increase in sales from ₹743 Cr in FY 2022 to ₹903 Cr in FY 2023, showcasing a robust growth trajectory. For FY 2024, sales are projected to further increase to ₹965 Cr, and the trailing twelve months (TTM) revenue stands at ₹1,056 Cr. Quarterly sales figures also reflect consistent growth, with a recorded ₹225 Cr in June 2023, rising to ₹250 Cr in December 2023. This upward trend underscores a strong demand for Expleo’s services, driven by digital transformation initiatives across various sectors. The consistent revenue growth positions Expleo favorably against industry peers, indicating a solid market presence and operational effectiveness.
Profitability and Efficiency Metrics
Expleo Solutions Ltd has demonstrated commendable profitability metrics, with a reported net profit of ₹104 Cr and a net profit margin of 10.07% for FY 2025. The operating profit margin (OPM) stood at 16%, reflecting effective cost management despite rising operational expenses. The company’s return on equity (ROE) of 16.3% and return on capital employed (ROCE) at 21.5% further indicate efficient utilization of equity and capital. The interest coverage ratio (ICR) is exceptionally high at 54.75x, suggesting that Expleo can comfortably meet its interest obligations, enhancing its financial stability. However, the operating profit has seen fluctuations, declining to ₹30 Cr in June 2025 from a high of ₹72 Cr in December 2022, signaling potential challenges in maintaining consistent operational efficiency.
Balance Sheet Strength and Financial Ratios
The balance sheet of Expleo Solutions Ltd reflects a solid financial foundation, with total assets amounting to ₹831 Cr and reserves reported at ₹688 Cr as of March 2025. The company maintains low borrowings of ₹20 Cr, indicating prudent financial management and minimal debt reliance. The current ratio stands at 3.90x, suggesting good short-term liquidity, while the price-to-book value (P/BV) ratio is 1.94x, indicating that the stock is reasonably valued compared to its book value. Additionally, the company’s cash conversion cycle (CCC) of 79 days highlights efficient working capital management. These financial ratios suggest that Expleo is well-positioned to navigate economic fluctuations and capitalize on growth opportunities, although the declining trend in ROCE to 21% in FY 2025 from 39% in FY 2023 warrants monitoring.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Expleo Solutions Ltd indicates strong promoter confidence, with promoters holding 71.05% of the total shares as of March 2025. This high level of ownership suggests alignment of interests between the management and shareholders. Foreign institutional investors (FIIs) have a minimal stake of 0.13%, while domestic institutional investors (DIIs) hold 0.84%, indicating limited institutional interest. The public shareholding stands at 28%, with a growing number of shareholders reaching 29,017, reflecting increasing retail investor interest. However, the low FII and DII participation may raise concerns regarding broader market confidence and liquidity. The stability in promoter holding coupled with a rising retail investor base may provide a buffer against market volatility.
Outlook, Risks, and Final Insight
Looking ahead, Expleo Solutions Ltd is well-positioned to benefit from the ongoing digital transformation trends across industries. The company’s strong financial metrics, including a high ICR and solid profit margins, provide a robust foundation for future growth. However, potential risks include the volatility in operating profits and the company’s reliance on a limited client base, which could impact revenue stability. Additionally, the decline in ROCE might suggest diminishing returns on capital investments, necessitating strategic adjustments. If Expleo can successfully navigate these challenges while capitalizing on emerging market opportunities, it may enhance its competitive position. Conversely, failure to address operational inefficiencies may hinder its growth trajectory, making it essential for management to focus on maintaining operational excellence and expanding its client portfolio.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 54.0 Cr. | 17.1 | 17.1/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 150 Cr. | 140 | 194/99.8 | 23.0 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 32.7 Cr. | 255 | 310/140 | 23.3 | 26.7 | 0.39 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 6.04 Cr. | 1.12 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,340.75 Cr | 552.19 | 87.11 | 123.78 | 0.55% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 212 | 220 | 240 | 231 | 225 | 234 | 250 | 255 | 252 | 259 | 258 | 256 | 260 |
| Expenses | 176 | 178 | 168 | 188 | 192 | 200 | 212 | 221 | 213 | 217 | 219 | 216 | 230 |
| Operating Profit | 37 | 42 | 72 | 43 | 33 | 34 | 38 | 34 | 39 | 42 | 39 | 40 | 30 |
| OPM % | 17% | 19% | 30% | 19% | 15% | 14% | 15% | 13% | 15% | 16% | 15% | 16% | 11% |
| Other Income | 1 | 1 | 13 | 4 | 2 | 2 | 11 | 2 | 2 | 13 | 3 | 5 | 7 |
| Interest | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 7 | 7 | 7 | 7 | 8 | 8 | 8 | 9 | 9 | 10 | 12 | 8 | 8 |
| Profit before tax | 31 | 36 | 77 | 39 | 26 | 27 | 41 | 26 | 31 | 44 | 28 | 36 | 28 |
| Tax % | 25% | 33% | 28% | 26% | 22% | 24% | 16% | 40% | 23% | 20% | 30% | 32% | 28% |
| Net Profit | 23 | 24 | 55 | 29 | 20 | 21 | 34 | 16 | 24 | 35 | 20 | 24 | 20 |
| EPS in Rs | 22.39 | 23.38 | 54.00 | 28.34 | 13.01 | 13.22 | 21.93 | 10.12 | 15.40 | 22.87 | 12.75 | 15.52 | 13.16 |
Last Updated: August 20, 2025, 11:00 am
Below is a detailed analysis of the quarterly data for Expleo Solutions Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 260.00 Cr.. The value appears strong and on an upward trend. It has increased from 256.00 Cr. (Mar 2025) to 260.00 Cr., marking an increase of 4.00 Cr..
- For Expenses, as of Jun 2025, the value is 230.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 216.00 Cr. (Mar 2025) to 230.00 Cr., marking an increase of 14.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 40.00 Cr. (Mar 2025) to 30.00 Cr., marking a decrease of 10.00 Cr..
- For OPM %, as of Jun 2025, the value is 11.00%. The value appears to be declining and may need further review. It has decreased from 16.00% (Mar 2025) to 11.00%, marking a decrease of 5.00%.
- For Other Income, as of Jun 2025, the value is 7.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Mar 2025) to 7.00 Cr., marking an increase of 2.00 Cr..
- For Interest, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Depreciation, as of Jun 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 28.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2025) to 28.00 Cr., marking a decrease of 8.00 Cr..
- For Tax %, as of Jun 2025, the value is 28.00%. The value appears to be improving (decreasing) as expected. It has decreased from 32.00% (Mar 2025) to 28.00%, marking a decrease of 4.00%.
- For Net Profit, as of Jun 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 4.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 13.16. The value appears to be declining and may need further review. It has decreased from 15.52 (Mar 2025) to 13.16, marking a decrease of 2.36.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:23 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 194 | 214 | 264 | 260 | 271 | 283 | 270 | 301 | 743 | 903 | 965 | 1,025 | 1,056 |
| Expenses | 155 | 177 | 210 | 219 | 231 | 230 | 217 | 231 | 618 | 703 | 816 | 859 | 901 |
| Operating Profit | 40 | 37 | 54 | 41 | 40 | 53 | 53 | 70 | 124 | 200 | 149 | 166 | 155 |
| OPM % | 20% | 17% | 20% | 16% | 15% | 19% | 20% | 23% | 17% | 22% | 15% | 16% | 15% |
| Other Income | 10 | 2 | 6 | 1 | 13 | 6 | 8 | 5 | 6 | 16 | 7 | 16 | 27 |
| Interest | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 3 | 3 | 3 |
| Depreciation | 6 | 5 | 4 | 5 | 6 | 6 | 6 | 6 | 19 | 28 | 34 | 39 | 36 |
| Profit before tax | 42 | 32 | 56 | 37 | 48 | 54 | 54 | 68 | 110 | 186 | 120 | 139 | 144 |
| Tax % | 29% | 32% | 34% | 36% | 33% | 32% | 26% | 26% | 39% | 28% | 24% | 26% | |
| Net Profit | 30 | 22 | 37 | 24 | 32 | 36 | 40 | 50 | 68 | 134 | 90 | 103 | 104 |
| EPS in Rs | 29.26 | 20.53 | 34.68 | 22.29 | 29.86 | 33.79 | 38.92 | 49.20 | 66.01 | 130.59 | 58.27 | 66.52 | 67.05 |
| Dividend Payout % | 31% | 117% | 69% | 108% | 80% | 0% | 0% | 0% | 0% | 6% | 0% | 75% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.67% | 68.18% | -35.14% | 33.33% | 12.50% | 11.11% | 25.00% | 36.00% | 97.06% | -32.84% | 14.44% |
| Change in YoY Net Profit Growth (%) | 0.00% | 94.85% | -103.32% | 68.47% | -20.83% | -1.39% | 13.89% | 11.00% | 61.06% | -129.89% | 47.28% |
Expleo Solutions Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 11% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 21% |
| 3 Years: | 14% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 16% |
| 3 Years: | -8% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 21% |
| 3 Years: | 20% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 3:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:13 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 98 | 91 | 98 | 116 | 118 | 128 | 142 | 192 | 379 | 515 | 596 | 620 | 688 |
| Borrowings | 12 | 10 | 0 | 0 | 0 | 0 | 0 | 7 | 15 | 26 | 26 | 30 | 20 |
| Other Liabilities | 27 | 54 | 73 | 43 | 63 | 53 | 62 | 56 | 185 | 174 | 128 | 165 | 192 |
| Total Liabilities | 147 | 165 | 182 | 171 | 191 | 192 | 214 | 264 | 594 | 730 | 765 | 831 | 916 |
| Fixed Assets | 27 | 24 | 25 | 27 | 22 | 19 | 26 | 25 | 108 | 142 | 131 | 113 | 91 |
| CWIP | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | 5 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 |
| Other Assets | 119 | 139 | 157 | 144 | 169 | 173 | 188 | 239 | 480 | 582 | 614 | 719 | 825 |
| Total Assets | 147 | 165 | 182 | 171 | 191 | 192 | 214 | 264 | 594 | 730 | 765 | 831 | 916 |
Below is a detailed analysis of the balance sheet data for Expleo Solutions Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
- For Reserves, as of Sep 2025, the value is 688.00 Cr.. The value appears strong and on an upward trend. It has increased from 620.00 Cr. (Mar 2025) to 688.00 Cr., marking an increase of 68.00 Cr..
- For Borrowings, as of Sep 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 30.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 10.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 192.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 165.00 Cr. (Mar 2025) to 192.00 Cr., marking an increase of 27.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 916.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 831.00 Cr. (Mar 2025) to 916.00 Cr., marking an increase of 85.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 91.00 Cr.. The value appears to be declining and may need further review. It has decreased from 113.00 Cr. (Mar 2025) to 91.00 Cr., marking a decrease of 22.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 825.00 Cr.. The value appears strong and on an upward trend. It has increased from 719.00 Cr. (Mar 2025) to 825.00 Cr., marking an increase of 106.00 Cr..
- For Total Assets, as of Sep 2025, the value is 916.00 Cr.. The value appears strong and on an upward trend. It has increased from 831.00 Cr. (Mar 2025) to 916.00 Cr., marking an increase of 85.00 Cr..
Notably, the Reserves (688.00 Cr.) exceed the Borrowings (20.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 28.00 | 27.00 | 54.00 | 41.00 | 40.00 | 53.00 | 53.00 | 63.00 | 109.00 | 174.00 | 123.00 | 136.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 105 | 97 | 75 | 60 | 92 | 59 | 103 | 74 | 85 | 97 | 94 | 79 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 105 | 97 | 75 | 60 | 92 | 59 | 103 | 74 | 85 | 97 | 94 | 79 |
| Working Capital Days | 68 | 23 | -7 | 8 | 21 | 15 | 50 | 48 | 46 | 93 | 112 | 67 |
| ROCE % | 40% | 29% | 51% | 31% | 38% | 40% | 38% | 39% | 36% | 39% | 20% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Invesco India Multicap Fund | 133,972 | 0.66 | 17.73 | 133,972 | 2025-04-22 15:56:58 | 0% |
| Invesco India Smallcap Fund | 127,985 | 0.59 | 16.93 | 127,985 | 2025-04-22 15:56:58 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 66.52 | 58.27 | 86.27 | 52.58 | 49.20 |
| Diluted EPS (Rs.) | 66.52 | 58.27 | 86.27 | 52.58 | 49.20 |
| Cash EPS (Rs.) | 91.85 | 79.96 | 157.79 | 60.32 | 54.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 409.69 | 393.78 | 512.06 | 248.93 | 196.90 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 409.69 | 393.78 | 512.06 | 248.93 | 196.90 |
| Revenue From Operations / Share (Rs.) | 660.31 | 621.69 | 881.09 | 394.57 | 293.50 |
| PBDIT / Share (Rs.) | 117.18 | 100.42 | 210.93 | 78.85 | 73.42 |
| PBIT / Share (Rs.) | 91.86 | 78.73 | 183.73 | 71.11 | 67.75 |
| PBT / Share (Rs.) | 89.72 | 77.05 | 181.53 | 70.37 | 66.72 |
| Net Profit / Share (Rs.) | 66.52 | 58.27 | 130.60 | 52.58 | 49.20 |
| NP After MI And SOA / Share (Rs.) | 66.52 | 58.27 | 130.60 | 52.58 | 49.20 |
| PBDIT Margin (%) | 17.74 | 16.15 | 23.93 | 19.98 | 25.01 |
| PBIT Margin (%) | 13.91 | 12.66 | 20.85 | 18.02 | 23.08 |
| PBT Margin (%) | 13.58 | 12.39 | 20.60 | 17.83 | 22.73 |
| Net Profit Margin (%) | 10.07 | 9.37 | 14.82 | 13.32 | 16.76 |
| NP After MI And SOA Margin (%) | 10.07 | 9.37 | 14.82 | 13.32 | 16.76 |
| Return on Networth / Equity (%) | 16.23 | 14.79 | 25.50 | 21.12 | 24.98 |
| Return on Capital Employeed (%) | 20.76 | 18.48 | 33.48 | 27.11 | 33.16 |
| Return On Assets (%) | 12.42 | 11.82 | 18.33 | 15.65 | 19.08 |
| Asset Turnover Ratio (%) | 1.28 | 1.29 | 1.84 | 1.46 | 1.36 |
| Current Ratio (X) | 3.90 | 5.77 | 3.30 | 3.84 | 4.11 |
| Quick Ratio (X) | 3.90 | 5.77 | 3.30 | 3.84 | 4.11 |
| Dividend Payout Ratio (NP) (%) | 75.16 | 8.58 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 54.43 | 6.25 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 24.84 | 91.42 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 45.57 | 93.75 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 54.75 | 59.74 | 95.85 | 106.51 | 71.28 |
| Interest Coverage Ratio (Post Tax) (X) | 32.08 | 35.66 | 60.35 | 72.02 | 48.77 |
| Enterprise Value (Cr.) | 1006.97 | 1697.97 | 1111.70 | 1571.40 | 398.52 |
| EV / Net Operating Revenue (X) | 0.98 | 1.76 | 1.23 | 3.88 | 1.32 |
| EV / EBITDA (X) | 5.54 | 10.89 | 5.14 | 19.44 | 5.29 |
| MarketCap / Net Operating Revenue (X) | 1.21 | 1.95 | 1.40 | 4.27 | 1.76 |
| Retention Ratios (%) | 24.83 | 91.41 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.94 | 3.08 | 2.41 | 6.77 | 2.62 |
| Price / Net Operating Revenue (X) | 1.21 | 1.95 | 1.40 | 4.27 | 1.76 |
| EarningsYield | 0.08 | 0.04 | 0.10 | 0.03 | 0.09 |
After reviewing the key financial ratios for Expleo Solutions Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For Diluted EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For Cash EPS (Rs.), as of Mar 25, the value is 91.85. This value is within the healthy range. It has increased from 79.96 (Mar 24) to 91.85, marking an increase of 11.89.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 660.31. It has increased from 621.69 (Mar 24) to 660.31, marking an increase of 38.62.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 117.18. This value is within the healthy range. It has increased from 100.42 (Mar 24) to 117.18, marking an increase of 16.76.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.86. This value is within the healthy range. It has increased from 78.73 (Mar 24) to 91.86, marking an increase of 13.13.
- For PBT / Share (Rs.), as of Mar 25, the value is 89.72. This value is within the healthy range. It has increased from 77.05 (Mar 24) to 89.72, marking an increase of 12.67.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For PBDIT Margin (%), as of Mar 25, the value is 17.74. This value is within the healthy range. It has increased from 16.15 (Mar 24) to 17.74, marking an increase of 1.59.
- For PBIT Margin (%), as of Mar 25, the value is 13.91. This value is within the healthy range. It has increased from 12.66 (Mar 24) to 13.91, marking an increase of 1.25.
- For PBT Margin (%), as of Mar 25, the value is 13.58. This value is within the healthy range. It has increased from 12.39 (Mar 24) to 13.58, marking an increase of 1.19.
- For Net Profit Margin (%), as of Mar 25, the value is 10.07. This value exceeds the healthy maximum of 10. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.07. This value is within the healthy range. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.23. This value is within the healthy range. It has increased from 14.79 (Mar 24) to 16.23, marking an increase of 1.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.76. This value is within the healthy range. It has increased from 18.48 (Mar 24) to 20.76, marking an increase of 2.28.
- For Return On Assets (%), as of Mar 25, the value is 12.42. This value is within the healthy range. It has increased from 11.82 (Mar 24) to 12.42, marking an increase of 0.60.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.28. It has decreased from 1.29 (Mar 24) to 1.28, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 3. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
- For Quick Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 2. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 75.16. This value exceeds the healthy maximum of 50. It has increased from 8.58 (Mar 24) to 75.16, marking an increase of 66.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 54.43. This value exceeds the healthy maximum of 50. It has increased from 6.25 (Mar 24) to 54.43, marking an increase of 48.18.
- For Earning Retention Ratio (%), as of Mar 25, the value is 24.84. This value is below the healthy minimum of 40. It has decreased from 91.42 (Mar 24) to 24.84, marking a decrease of 66.58.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 45.57. This value is within the healthy range. It has decreased from 93.75 (Mar 24) to 45.57, marking a decrease of 48.18.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 54.75. This value is within the healthy range. It has decreased from 59.74 (Mar 24) to 54.75, marking a decrease of 4.99.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.08. This value is within the healthy range. It has decreased from 35.66 (Mar 24) to 32.08, marking a decrease of 3.58.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,006.97. It has decreased from 1,697.97 (Mar 24) to 1,006.97, marking a decrease of 691.00.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.76 (Mar 24) to 0.98, marking a decrease of 0.78.
- For EV / EBITDA (X), as of Mar 25, the value is 5.54. This value is within the healthy range. It has decreased from 10.89 (Mar 24) to 5.54, marking a decrease of 5.35.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
- For Retention Ratios (%), as of Mar 25, the value is 24.83. This value is below the healthy minimum of 30. It has decreased from 91.41 (Mar 24) to 24.83, marking a decrease of 66.58.
- For Price / BV (X), as of Mar 25, the value is 1.94. This value is within the healthy range. It has decreased from 3.08 (Mar 24) to 1.94, marking a decrease of 1.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Expleo Solutions Ltd:
- Net Profit Margin: 10.07%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.76% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.23% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.9
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.8 (Industry average Stock P/E: 87.11)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.07%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 6A, Sixth Floor, Prince Infocity II, Chennai (Madras) Tamil Nadu 600096 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ralph Franz Gillessen | Chairman & Non-Exe.Director |
| Mr. Phani Tangirala | Managing Director & CEO |
| Mr. Rajesh Krishnamurthy | Non Executive Director |
| Mr. Narayanan Subramaniam | Independent Director |
| Dr. Srivardhini Keshavamurthy Jha | Independent Director |
| Dr. Varadharajan Sridhar | Independent Director |
| Ms. Shalini Kalsi Kamath | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Expleo Solutions Ltd?
Expleo Solutions Ltd's intrinsic value (as of 27 December 2025) is 918.32 which is 7.43% lower the current market price of 992.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,539 Cr. market cap, FY2025-2026 high/low of 1,440/686, reserves of ₹688 Cr, and liabilities of 916 Cr.
What is the Market Cap of Expleo Solutions Ltd?
The Market Cap of Expleo Solutions Ltd is 1,539 Cr..
What is the current Stock Price of Expleo Solutions Ltd as on 27 December 2025?
The current stock price of Expleo Solutions Ltd as on 27 December 2025 is 992.
What is the High / Low of Expleo Solutions Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Expleo Solutions Ltd stocks is 1,440/686.
What is the Stock P/E of Expleo Solutions Ltd?
The Stock P/E of Expleo Solutions Ltd is 14.8.
What is the Book Value of Expleo Solutions Ltd?
The Book Value of Expleo Solutions Ltd is 453.
What is the Dividend Yield of Expleo Solutions Ltd?
The Dividend Yield of Expleo Solutions Ltd is 5.04 %.
What is the ROCE of Expleo Solutions Ltd?
The ROCE of Expleo Solutions Ltd is 21.5 %.
What is the ROE of Expleo Solutions Ltd?
The ROE of Expleo Solutions Ltd is 16.3 %.
What is the Face Value of Expleo Solutions Ltd?
The Face Value of Expleo Solutions Ltd is 10.0.